Omacor medication errors
Executive Summary
The Institute of Safe Medication Practices is recommending that the name of Reliant's hypertriglyceridemia therapy Omacor (omega-3-acid ethyl esters) be changed due to similarity with Xanodyne's antifibrinolytic agent Amicar (aminocaproic acid). "Prescriptions for Omacor have just begun to arrive in pharmacies, but we've already heard name-related safety issues. A pharmacist reported an error in which a telephone order of Omacor 1 g B.I.D. was misheard as Amicar 1 g B.I.D.," the Nov. 3 issue of ISMP's Medication Safety Alert! says. Reliant launched Omacor in October, following approval in November 2004 (1"The Pink Sheet" June 6, 2005, p. 9)...
You may also be interested in...
Reliant Omacor Launch Funded Through IPO; Launch Set For Late 2005
Reliant Pharmaceuticals will raise cash through an initial public offering to pay for a sales force expansion for the launch of the triglyercide therapy Omacor
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.